Medicare Enrolled
Dr. Dhatri Kodali, MD
Internal Medicine · Webster, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kodali from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kodali?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kodali
Dr. Dhatri Kodali is an internal medicine specialist in Webster, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kodali performed 100,604 Medicare services across 3,089 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kodali received a total of $2,317 from 43 pharmaceutical and/or device companies across 94 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kodali is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 0% volume in TX
$2,317 industry payments
Medicare Practice Summary
Medicare Utilization ↗100,604
Medicare services
Top 0% in TX for internal medicine
3,089
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,589 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
41,820 | $0 | $5 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
10,400 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
10,050 | $0 | $5 |
| Pembrolizumab injection (Keytruda) | 10,000 | $43 | $137 |
| Paclitaxel chemotherapy injection | 7,342 | $0 | $8 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
5,400 | $0 | $2 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,315 | $0 | $3 |
| Denosumab injection (Prolia/Xgeva) | 2,220 | $18 | $67 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,152 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,099 | $8 | $36 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,045 | $0 | $1 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
929 | $10 | $64 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
695 | $95 | $368 |
| Anti-nausea injection (Aloxi/palonosetron) | 690 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 455 | $0 | $24 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
327 | $23 | $157 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
300 | $2 | $300 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
214 | $105 | $707 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
178 | $6 | $31 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
174 | $35 | $143 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
172 | $11 | $96 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
148 | $50 | $313 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
134 | $6 | $431 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
126 | $2 | $13 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
120 | $96 | $357 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
112 | $12 | $108 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
97 | $58 | $211 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
96 | $23 | $161 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
77 | $52 | $344 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
77 | $1 | $7 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
73 | $58 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
56 | $117 | $565 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 56 | $90 | $657 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
51 | $4 | $25 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
48 | $1 | $8 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
43 | $1,169 | $4,802 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
38 | $174 | $1,067 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
36 | $48 | $821 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
31 | $6 | $34 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
29 | $105 | $470 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
28 | $4 | $22 |
| New patient office visit, complex (60-74 min) | 24 | $177 | $709 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
24 | $57 | $247 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
20 | $15 | $94 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
20 | $23 | $145 |
| Whole body nuclear medicine scan with CT A combined imaging procedure using nuclear medicine and CT scans to visualize the entire body. |
18 | $1,182 | $4,929 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
16 | $17 | $114 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
15 | $56 | $686 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
14 | $5 | $26 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
42.4% high complexity
52.9% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,317
Total received (2019-2024)
Avg $463/year across 5 years
Top 27% in TX for internal medicine
43
Companies
94
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,199 (94.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$117 (5.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$452
2023
$686
2022
$886
2021
$77
2019
$216
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$182
Karyopharm Therapeutics Inc.
$180
AstraZeneca Pharmaceuticals LP
$177
GENZYME CORPORATION
$169
Exelixis Inc.
$144
PFIZER INC.
$124
Janssen Biotech, Inc.
$95
G1 Therapeutics, Inc.
$94
ARRAY BIOPHARMA INC
$66
Myriad Genetic Laboratories, Inc.
$65
Merck Sharp & Dohme LLC
$58
MorphoSys, US Inc.
$58
PharmaEssentia USA Corporation
$56
Deciphera Pharmaceuticals Inc.
$54
Amgen Inc.
$51
Novo Nordisk Inc
$50
Gilead Sciences, Inc.
$46
Eisai Inc.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$42
Stemline Therapeutics Inc.
$39
Sirtex Medical Inc
$37
PUMA BIOTECHNOLOGY, INC.
$36
CTI BioPharma Corp.
$33
Apellis Pharmaceuticals, Inc.
$30
JAZZ PHARMACEUTICALS INC.
$26
Bayer Healthcare Pharmaceuticals Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$23
Teleflex LLC
$23
Puma Biotechnology, Inc.
$23
ADC Therapeutics America, Inc.
$22
Sobi, Inc
$22
E.R. Squibb & Sons, L.L.C.
$21
TAIHO ONCOLOGY, INC.
$21
EMD Serono, Inc.
$21
Pharmacosmos Therapeutics Inc.
$19
Tactile Systems Technology Inc
$19
Sumitomo Pharma America, Inc.
$19
Taiho Oncology, Inc.
$18
Adaptive Biotechnologies Corporation
$18
Clovis Oncology, Inc.
$18
AVEO Pharmaceuticals, Inc.
$18
Blueprint Medicines Corporation
$15
Alnylam Pharmaceuticals Inc.
$14
Top 3 companies account for 23.3% of total payments
Associated products mentioned in payments ›
ADAKVEO · BESPONSA · BESREMI · CABOMETYX · CALQUENCE · COSELA · Cabometyx · DARZALEX · DOPTELET · ENHERTU · ENJAYMO · Empaveli · FOTIVDA · Flexitouch Plus · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · Lenvima · MONJUVI · MONOFERRIC · NERLYNX · Nplate · ORGOVYX · Orserdu · PROMACTA · QINLOCK · QuikClot · RYBREVANT · Rubraca · Rybelsus · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SUTENT · Stivarga · TABRECTA · Trodelvy · Vonjo · XALKORI · XPOVIO · XTANDI · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $2 per 100 Medicare services performed
Geographic Context
Internal medicine physicians within 10 mi
1,900
Per 100K population
39.9
County median income
$73,104
Nearest hospital
HCA HOUSTON HEALTHCARE CLEAR LAKE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kodali is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kodali experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Kodali performed 41,820 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kodali receive payments from pharmaceutical companies?
Yes. Dr. Kodali received a total of $2,317 from 43 companies across 94 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kodali's costs compare to other internal medicine physicians in Webster?
Dr. Kodali's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kodali) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Webster
Browse internal medicine physicians in Webster ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Karyopharm Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Karyopharm Therapeutics Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology